TMEM52B and renal carcinoma: A study found that reduced TMEM52B expression was associated with unfavorable survival outcomes and von Hippel-Lindau mutation in patients with renal cancer, suggesting the downregulation of TMEM52B expression and the downregulation of TMEM52B in the occurrence of renal cancer [43].